Progressive meningiomas featuring CDKN2A/B homozygous deletion and lacking NF2 mutations were recently categorized in the NF2 agnostic pattern, which is characterized by mutations in TP53 or TERT promoter [9]. The gene discussed is NF2; the disease is meningioma.